Eric Adams
Chief Executive Officer at INMED PHARMACEUTICALS INC.
Net worth: 16 001 $ as of 2024-03-30
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Andrew Hull | M | 61 | 8 years | |
| Janet Grove | F | 57 | 2 years | |
| Richard Glickman | M | 65 |
enGene, Inc.
 enGene, Inc. BiotechnologyHealth Technology enGene, Inc. develops therapeutic solutions for the treatment of metabolic diseases. It operates as a biotechnology company which develops a mucosal immunotherapy platform for treating several prevalent, chronic diseases including inflammatory bowel disease and diabetes. The firm also develops proprietary, non-integrating biopolymer based nucleotide DNA and siRNA delivery technology that facilitates localized delivery of immune-modulating proteins to the intestinal mucosa for treating various immune disorders. The company was founded in 1999 by Anthony T. Cheung, John C. Brown, Timothy J. Kieffer, and Francis John Gargiulo and is headquartered in Vancouver, Canada. | 13 years |
| Alexandra Mancini | F | - |
QLT, Inc.
 QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | 8 years |
| Colin Clancy | M | - | - | |
| Bryan Baldasare | M | 58 | 2 years | |
| Bruce Sifton | M | - |
Ronin8 Technologies Ltd.
 Ronin8 Technologies Ltd. Environmental ServicesIndustrial Services Ronin8 Technologies Ltd. provides materials recovery facilities. It captures the metals in electronic waste without destroying the non-metals. The company was founded by Bruce Sifton and Peter Holgate in 2015 and is headquartered in Vancouver, Canada. | 9 years |
| Michael Woudenberg | M | - | 6 years | |
| Nicole Lemerond | F | 49 | 2 years | |
| Eric Hsu | M | - | 6 years | |
| Gerard Griffin | M | - | 2 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Julia G. Levy | M | 89 |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | 21 years |
| Garner William | M | 58 | 6 years | |
| Lawrence John Wood | M | 87 |
enGene, Inc.
enGene, Inc. BiotechnologyHealth Technology enGene, Inc. develops therapeutic solutions for the treatment of metabolic diseases. It operates as a biotechnology company which develops a mucosal immunotherapy platform for treating several prevalent, chronic diseases including inflammatory bowel disease and diabetes. The firm also develops proprietary, non-integrating biopolymer based nucleotide DNA and siRNA delivery technology that facilitates localized delivery of immune-modulating proteins to the intestinal mucosa for treating various immune disorders. The company was founded in 1999 by Anthony T. Cheung, John C. Brown, Timothy J. Kieffer, and Francis John Gargiulo and is headquartered in Vancouver, Canada.
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | 6 years |
| Sazzad Hossain | M | - | 38 years | |
| Martin Bott | M | - | 2 years | |
| Adam Daniel Cutler | M | 50 | 7 years | |
| Paul Hastings | M | 64 |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | 4 years |
| Jeffrey Charpentier | M | - | - | |
| Steven M. Rauscher | M | 70 | 18 years | |
| Catherine A. Sazdanoff | F | 68 | 3 years | |
| John B. Thomas | M | - | 18 years | |
| David A. L. Owen | M | 85 | - | |
| Cameron R. Nelson | M | 58 |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | 12 years |
| Jonathan Tegge | M | 34 | 2 years | |
| David Laskow-Pooley | M | 69 | 6 years | |
| Peter C. Gonze | M | 74 | 3 years | |
| Michael DiTullio | M | 56 | 4 years | |
| Bruce A. Beutel | M | 60 | 12 years | |
| Michael Fiechtner | M | - | 12 years | |
| Robert Michael | M | 53 | 19 years | |
| John Robert Ducker | M | 64 | - | |
| Bruce H. Phelps | M | - | 12 years | |
| R. James Danehy | M | - | 21 years | |
| David Stamler | M | 63 | 4 years | |
| Brenda Edwards | F | - | - | |
| Robert Connelly | M | 63 | - | |
| Andrew Dunlop | M | 52 |
enGene, Inc.
enGene, Inc. BiotechnologyHealth Technology enGene, Inc. develops therapeutic solutions for the treatment of metabolic diseases. It operates as a biotechnology company which develops a mucosal immunotherapy platform for treating several prevalent, chronic diseases including inflammatory bowel disease and diabetes. The firm also develops proprietary, non-integrating biopolymer based nucleotide DNA and siRNA delivery technology that facilitates localized delivery of immune-modulating proteins to the intestinal mucosa for treating various immune disorders. The company was founded in 1999 by Anthony T. Cheung, John C. Brown, Timothy J. Kieffer, and Francis John Gargiulo and is headquartered in Vancouver, Canada. | 3 years |
| Terese Gieselman | F | 62 | 5 years | |
| Sandra Rose MacKay | F | 64 |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | 4 years |
| Peter Hnik | M | - |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | 7 years |
| Martin A. Kaufman | M | - |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | 4 years |
| Azita Saleki-Gerhardt | M | 60 | 19 years | |
| Paul Erickson | M | - |
enGene, Inc.
enGene, Inc. BiotechnologyHealth Technology enGene, Inc. develops therapeutic solutions for the treatment of metabolic diseases. It operates as a biotechnology company which develops a mucosal immunotherapy platform for treating several prevalent, chronic diseases including inflammatory bowel disease and diabetes. The firm also develops proprietary, non-integrating biopolymer based nucleotide DNA and siRNA delivery technology that facilitates localized delivery of immune-modulating proteins to the intestinal mucosa for treating various immune disorders. The company was founded in 1999 by Anthony T. Cheung, John C. Brown, Timothy J. Kieffer, and Francis John Gargiulo and is headquartered in Vancouver, Canada. | 4 years |
| William Henry Mullen | M | - | 3 years | |
| Geertrui Vanhove | M | 59 | 2 years | |
| Patrick J. Eagan | M | 66 | 18 years | |
| Margo Heath-Chiozzi | M | 67 | 8 years | |
| Lisa Giles | F | 65 | 10 years | |
| Karsten Wellner | M | 63 | 12 years | |
| David Granville | M | - |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | 6 years |
| Matt van Bergen | M | - | 2 years | |
| Sharon D. Larkin | F | 60 | 23 years | |
| Nancy Avila | F | 57 | 22 years | |
| Bill Welch | M | 62 | 5 years | |
| Edwin Levy | M | - |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | 14 years |
| Gary Stevenson | M | - | 7 years | |
| Robert Walder | M | 71 | 6 years | |
| David Thompson | M | 82 | 21 years | |
| O. Ralph Edwards | M | 89 | - | |
| Alan C. Mendelson | M | 76 |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | 6 years |
| Paul D. Rubin | M | 70 | 6 years | |
| Timothy Ring | M | 66 | 10 years | |
| Christopher Kuebler | M | 70 | 8 years | |
| Shi-Chung Ng | M | 69 | 11 years | |
| Chung Chiang Hsu | M | 75 | 15 years | |
| Irene C. Kerr | F | 74 | 10 years | |
| Robert J. Koska | M | 66 | - | |
| Therese Hayes | F | - |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | - |
| Hugh Griffith | M | 56 | 6 years | |
| Perry Karsen | M | 69 | 11 years | |
| George F. Horner | M | 80 | 17 years | |
| Robert Hooper | M | 77 | 4 years | |
| William C. Houghton | M | 81 | 11 years | |
| Douglas Liu | M | 62 | 10 years | |
| Peter Holgate | M | - |
Ronin8 Technologies Ltd.
Ronin8 Technologies Ltd. Environmental ServicesIndustrial Services Ronin8 Technologies Ltd. provides materials recovery facilities. It captures the metals in electronic waste without destroying the non-metals. The company was founded by Bruce Sifton and Peter Holgate in 2015 and is headquartered in Vancouver, Canada. | - |
| David Milligan | M | 83 | 17 years | |
| Bruce Colwill | M | - | 3 years | |
| R. MacKay-Dunn | M | 73 |
enGene, Inc.
enGene, Inc. BiotechnologyHealth Technology enGene, Inc. develops therapeutic solutions for the treatment of metabolic diseases. It operates as a biotechnology company which develops a mucosal immunotherapy platform for treating several prevalent, chronic diseases including inflammatory bowel disease and diabetes. The firm also develops proprietary, non-integrating biopolymer based nucleotide DNA and siRNA delivery technology that facilitates localized delivery of immune-modulating proteins to the intestinal mucosa for treating various immune disorders. The company was founded in 1999 by Anthony T. Cheung, John C. Brown, Timothy J. Kieffer, and Francis John Gargiulo and is headquartered in Vancouver, Canada. | 7 years |
| Todd Davis | M | 63 | 5 years | |
| Terri Sebree | F | 66 | 8 years | |
| James J. Egan | M | 73 | 9 years | |
| Joshua Blacher | M | 52 | - | |
| Alain H. Curaudeau | M | 67 |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | 8 years |
| William Newell | M | 66 |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | 3 years |
| Matthew R. Hooper | M | 66 | 5 years | |
| Alan S. Rosenthal | M | - | 6 years | |
| Philippe G. Prokocimer | M | 74 | 7 years | |
| Friedrich von Bohlen und Halbach | M | 60 | - | |
| Ken Galbraith | M | 61 |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | 14 years |
| Sarah Li | F | - | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 47 | 51.65% |
| Canada | 41 | 45.05% |
| Germany | 3 | 3.30% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Eric Adams
- Personal Network
